Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Health Care Policies and Covid-19 Prevalence: Is There Any Association? Publisher Pubmed



Nejadghaderi SA1, 2 ; Saghazadeh A1, 3 ; Rezaei N3, 4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  2. 2. School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: International Journal of Health Services Published:2022


Abstract

The coronavirus disease 2019 (COVID-19) pandemic has affected almost all countries and territories. As of December 6, 2020, the United States of America and India have the highest prevalence. Each country has implemented different strategies to control and reduce the spread of disease. Here, the association between prevalence number and health policies is evaluated by comparing 2 groups of countries: (1) Italy, the United States of America, Germany, Spain, and India with a higher prevalence than a linear trend line; and (2) Singapore and China with a lower or equal prevalence than linear forecasts. A rapid overview revealed that many countries have similar strategies for controlling COVID-19, including the suspension of air travel, the lockdown on the cities with the most cases detected, active case findings, monitoring of close contacts, and raising public awareness. Also, they used a gradual and phased plan to reopen activities. So, the difference between countries in the burden of COVID-19 can be attributable to the strict mode and nonstrict mode of implementation of strategies. Limitations at the national levels call for systemic rather than regional strategies. © The Author(s) 2021.
Other Related Docs
10. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
12. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
14. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
15. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
16. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
19. The Epidemiologic Aspects of Covid-19 Outbreak: Spreading Beyond Expectations, Advances in Experimental Medicine and Biology (2021)
21. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
22. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
23. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
25. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
26. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
33. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
37. Immunotherapy for Sars-Cov-2: Potential Opportunities, Expert Opinion on Biological Therapy (2020)
38. Serological Tests for Covid-19: Potential Opportunities, Cell Biology International (2021)
39. Covid-19 Pandemic Is Not the Time of Trial and Error, American Journal of Emergency Medicine (2021)
42. Anti-Ige Monoclonal Antibodies As Potential Treatment in Covid-19, Immunopharmacology and Immunotoxicology (2021)
44. Covid-19 and Medical Biotechnology, Avicenna Journal of Medical Biotechnology (2020)
47. Potential Therapeutic Approach of Intravenous Immunoglobulin Against Covid-19, Allergy# Asthma and Clinical Immunology (2021)
48. Role of Toll-Like Receptors in the Pathogenesis of Covid-19, Journal of Medical Virology (2021)